Have an "Exit Plan" for Antipsychotics in Dementia Patients

June 2017

Growing interest in Nuedexta (dextromethorphan/quinidine) will raise questions about how to treat agitation or psychosis in dementia patients.

About one in 6 nursing home residents take an antipsychotic.

But benefits are small at best. Plus, there's one more death for every 50 to 100 dementia patients on an atypical for 8 to 12 weeks.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
300+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscription Options

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Psychiatry Have an "Exit Plan" for Antipsychotics in Dementia Patients
Opioids Suggest Alternatives to Codeine and Tramadol in Kids and Breastfeeding Women
PPIs Know When Short or Long Term Use of PPIs is Appropriate
Diabetes Meds Expect a Limited Role for Basal Insulin/GLP-1 Agonist Combo Products
Antithrombotics Don't Be Alarmed if a Low Anticoagulant Dose is Used to Prevent Recurrent Clots
Ear Health Help Choose Appropriate Ear Drops for Kids With Ear Tubes
Fibromyalgia Emphasize Nondrug Measures for Fibromyalgia
Psychiatry Consider Ingrezza When Treatment Is Needed for Tardive Dyskinesia
Migraine Suggest Therapies to Prevent Menstrual Migraine
Acute Pain Dispel the Myth That Ketorolac Is a Stronger NSAID
Practice Stay Alert for Visually Impaired Patients
Vaccines Use Simple Strategies to Identify Patients Who May Need Vaccines